Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer

Condition:   Triple Negative Breast Cancer Interventions:   Drug: Ipatasertib;   Drug: Capecitabine;   Drug: Eribulin;   Drug: Carboplatin;   Drug: Gemcitabine Sponsors:   MedSIR;   Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials